Acknowledgement: ‘This is a presentation of independent research funded by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research Programme (Grant Reference Number RP-PG-0613-20007). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health’.
You will need Adobe Acrobat reader to download the publications below.
- Development of a core outcome set for effectiveness trials aimed at optimising prescribing in older adults in care homes
- The Care Home Independent Prescribing Pharmacist Study (CHIPPS)—a non-randomised feasibility study of independent pharmacist prescribing in care homes
- Not just a ‘tick box exercise’ – meaningful public involvement in research
- Systematic review and narrative synthesis of pharmacist provided medicines optimisation services in care homes for older people to inform the development of a generic training or accreditation process
- Protocol for the process evaluation of a cluster randomised controlled trial to determine the effectiveness and cost-effectiveness of independent pharmacist prescribing in care home: the CHIPPS study
- Protocol for a cluster randomised controlled trial to determine the effectiveness and cost-effectiveness of independent pharmacist prescribing in care homes: the CHIPPS study
- “Everyone needs to understand each other’s systems”: Stakeholder views on the acceptability and viability of a Pharmacist Independent Prescriber role in care homes for older people in the UK
- Lessons learned from CHIPPS (Care Homes Independent Pharmacist Prescribing Study): how feasibility studies informed ultimate randomised controlled trial design
Conferences and Presentations
- CHIPPS: Care Homes Independent Pharmacist Prescribing Service: Development and delivery of a cluster randomised controlled trial to determine both its effectiveness and cost-effectiveness - Poster
- Abstracts from Royal Pharmaceutical Society Science and Research Summit 19 June 2020, London UK